Highest Quality Supplements Since 1980

Life Extension Magazine

<< Back to May 2002

Does Vitamin E Prevent Breast Cancer?

May 2002

By Dr. Michele Morrow, Board Certified Physician

References for "Does Vitamin E Prevent Breast Cancer?"

  1. Lifetime Probability of Breast Cancer in American Women. Cancer Facts. National Cancer Institute http://cis.nci.nih.gov/fact/5_6.html.
  2. Schwenke D.C. Does lack of tocopherols and tocotriemols put women at increased risk of breast cancer? Journal of Nutritional Biochemistry 13 (2002) 2-20.
  3. Mannisto S., et al. Diet and risk of breast cancer in a case-control study: does the threat of disease have on influence on recall bias? J. Clin. Epidemiol. 52 (1999) 429-439.
  4. Bohike K., et al. Vitamins A, C and E and the risk of breast cancer: results from a case-control study in Greece. Br. J. Cancer 79 (1999) 23-29.
  5. Ambrosone C.B., et al. Interaction of family history of breast cancer and dietary antioxidants with breast cancer risk. (New York, United States), Cancer Causes & Control 6 (1995) 407-415.
  6. Ronco A., et al. Vegetables, fruits and related nutrients and risk of breast cancer: a case-control study in Uruguay. Nutrition & Metabolism 35 (1999) 111-119.
  7. Freudenheim J.L., et al. Premenopausal breast cancer risk and intake of vegetables, fruits and related nutrients. J. Natl. Cancer Inst. 88 (1996) 340-348.
  8. Mezzetti M., et al. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J. Natl. Cancer Inst. 90 (1998) 389-394.
  9. Richardson S., et al. The role of fat, animal protein and some vitamin consumprtion in breast cancer: a case control study in southern France. Int. J. Cancer 48 (1991) 1-9.
  10. Wu D, et al. In vitro supplementation with different tocopherol homologues can affect the function of immune cells in old mice. Free Radic Biol Med 2000 Feb 15;28(4):643-51.
  11. Zhong S., et al. Dietary crotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst. 91 (1999) 547-556.
  12. Rohan T.E., et al. Dietary fiber, vitamins A, C and E, and risk of breast cancer: a cohort study. Cancer Causes & Control 4 (1993) 29-37.
  13. Hunter D.J., et al. A prospective study of the intake of vitamin-C, vitamin-E, and vitamin-A and the risk of breast cancer. New Engl. J. Med. 329 (1993) 234-240.
  14. Kushi L.H., et al. Intake of vitamins A, C and E, and postmenopausal breast cancer - The Iowa Women's Health Study. Am. J. Epidemiol. 144 (1996) 165-174.
  15. Shibata A., et al. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly-a prospective study. Br. J. Cancer. 66 (1992) 673-679.
  16. London S.J., et al. Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer Causes & Control 3 (1992) 503-512.
  17. Comstock G.W., et al. Prediagnostic serum levels of carotenoids and vitamin-E as related to subsequent cancer in Washington County, Maryland. Am. J. Clin. Nutr. 53 (1991) S260-S264.
  18. Dorgan J.F., et al. Relationship of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes & Control 9 (1998) 89-97.
  19. Chajes V., et al. Alpha-tocopherol and hydroperoxide content in breast adipose tissue from patients with breast tumours. Int. J. Cancer 67 (1996) 170-175.
  20. Zhu Z., et al. Vitamin E concentration in breast adipose tissue of breast cancer patients (Kupio, Finland). Cancer Causes & Control 7 (1996) 591-595.
  21. van't Veer P, et al. Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidant, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidem. Biomarkers Prevent. 5 (1996) 441-447.
  22. Charpentier A, et al. RRR-alpha-Tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-beta (TGF-beta) by human breast cancer cells. Nutr. Cancer (USA) , 1993, 19/3 (225-239).
  23. Zhao B, et al. Involvement of activator protein-1 (AP-1) in induction of apoptosis by Vitamin E succinate in human breast cancer cells. Molecular Carcinogenesis (USA), 1997, 19/3 (180-190).
  24. Turley J.M.; et al. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: Increased binding of cyclin a negatively regulates E2F transactivation activity. Cancer Research (USA), 1997, 57/13 (2668-2675).
  25. Turley J.M.; et al. Vitamin E succinate induces fas-mediated apoptosis in estrogen receptor-negative human breast cancer cells. Cancer Research (USA) , 1997, 57/5 (881-890).
  26. Djuric Z, et al. Growth inhibition of MCF-7 and MCF-10A human-breast cells by alpha-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs. Cancer Letters (Ireland), 1997, 111/1-2 (133-139).
  27. Charpentier A, et al. RRR-alpha-tocopheryl succinate enhances TGF-beta1, -beta2, and -beta3 and TGF- betaR-II expression by human MDA-MB-435 breast cancer cells. Nutrition and Cancer (USA) , 1996, 26/2 (237-250).
  28. You H, et al. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. Cell Growth Differ 2001 Sep;12(9):471-80.
  29. Yu W, et al. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells. Cancer Res 2001 Sep 1;61(17):6569-76.
  30. Malafa MP, et al. Vitamin E succinate promotes breast cancer tumor dormancy. J Surg Res 2000 Sep;93(1):163-70.
  31. Heisler T, et al. Peptide YY and vitamin E inhibit hormone-sensitive and -insensitive breast cancer cells. J Surg Res 2000 Jun 1;91(1):9-14.
  32. Tesarik J, et al. Estradiol modulates breast cancer cell apoptosis: a novel nongenomic steroid action relevant to carcinogenesis. Steroids 1999 Jan-Feb;64(1-2):22-7.
  33. Yu W, et al. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer Res 1999 Feb 15;59(4):953-61.
  34. Yu W, et al. RRR-alpha-tocopheryl succinate induction of prolonged activation of c-jun amino-terminal kinase and c-jun during induction of apoptosis in human MDA-MB-435 breast cancer cells. Mol Carcinog 1998 Aug;22(4):247-57.
  35. Yu W, et al. Evidence for role of transforming growth factor-beta in RRR-alpha-tocopheryl succinate-induced apoptosis of human MDA-MB-435 breast cancer cells. Nutr Cancer 1997;27(3):267-78.
  36. Nesaretnam, K. et al. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 33 (1998) 461-469.
  37. Gunthrie N., et al. Inhibition of proliferation of estrogen receptor- negative MDA-MB-435 and positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination. J. Nutr. 127 (1997) S544-S548.
  38. Nesaretnam K., et al. Tocotrienols inhibit growth of ZR-75-J breast cancer cells. Int. J. Food Sci. Nutr. 51 (Suppl) (200) S95-S103.
  39. Nesaretnam K., et al. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30 (1995) 1139-1143.
  40. Gundimeda U., et al. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J. Biol. Chem. 271 (1996) 13504-13514.
  41. Sigournas G., et al. dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr. Cancer 28 (1997) 30-35.
  42. McIntyre B.S., et al. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells. Exp. Biol. Med. 224 (2000) 292-301.
  43. Yu W, et al. Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols. Nutr. Cancer 33 (1999) 26-32.
  44. Yap S.P., et al. Pharmacokinetics and biovailability of alpha-, gamma- and delta-tocotrienols under different food status. J. Pharm. Pharmacol. 53 (2001) 67-71.
  45. Qureshi A.A., et al. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (Palmvitee). Am. J. Clin. Nutr. 53 (1991) S1021-S1026.
  46. Chow C.K.. Distribution of tocopherols in human plasma and red blood cells. Am. J. Nutr. 28 (1975) 756-760.
  47. Wahlqvist M.L., et al. Differential serum responses of tocopherols and tocotrienols during vitamin supplementation in hypercholesterolaemic individuals without changes in coronary risk factors. Nutr. Res. 12 (Suppl 1) (1992) S181-S201.
  48. Hayes K.C., et al. Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols- observations in humans and hamsters. Proc. Soc. Exp. Biol. Med. 202 (1993) 353-359.
  49. Ohrvall,M. et al. Tocopherol concentrations in adipose tissue. Relationships of tocopherol concentrations and fatty acid composition in serum in a reference population of Sedish men and women. Eur. J. Clin. Nutr. 48 (1994) 212-218.
  50. Dimitrov N. V., et al. Some aspects of vitamin E related to humans and breast cancer prevention. Adv. Exp. Med. Biol. 364 (1994) 119-127.
  51. Qureshi A. A., et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30 (1995) 1171-1177.
  52. Tomeo A. C., et al. Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 30 (1995) 1179-1183.
  53. Chen CL, et al. Hormone replacement therapy in relation to breast cancer. JAMA 2002 Feb 13;287(6):734-41.
  54. Paolisso G, et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. J Clin Endocrinol Metab 2000 Jan;85(1):109-15.
  55. Anderson JW, et al. Antioxidant supplementation effects on low-density lipoprotein oxidation for individuals with type 2 diabetes mellitus. J Am Coll Nutr 1999 Oct;18(5):451-61.
  56. Gazis A, et al. Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus. Diabet Med 1999 Apr;16(4):304-11.
  57. Davi G, et al. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999 Jan 19;99(2):224-9.
  58. Tutuncu NB, et al. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes: a preliminary study. Diabetes Care 1998 Nov;21(11):1915-8.
  59. Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 1998;7(1-2):113-74.
  60. Sokoloski JA, et al. Induction of the differentiation of HL-60 promyelocytic leukemia cells by vitamin E and other antioxidants in combination with low levels of vitamin D3: possible relationship to NF-kappaB. Leukemia 1997 Sep;11(9):1546-53.
  61. Swain RA, et al. Therapeutic uses of vitamin E in prevention of atherosclerosis. Altern Med Rev 1999 Dec;4(6):414-23.
  62. Wu D, et al. Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 1999 Dec;147(2):297-307.
  63. Davey PJ, et al. Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Cambridge Heart Antioxidant Study. Am J Cardiol 1998 Aug 15;82(4):414-7.
  64. Copp RP, et al. Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res 1999 Mar 20;822(1-2):80-7.
  65. Tanyel MC, et al. Neurologic findings in vitamin E deficiency. Am Fam Physician 1997 Jan;55(1):197-201.
  66. Arria AM, et al. Vitamin E deficiency and psychomotor dysfunction in adults with primary biliary cirrhosis. Am J Clin Nutr 1990 Aug;52(2):383-90.
  67. Larsen PD, et al. Vitamin E deficiency associated with vision loss and bulbar weakness. Ann Neurol 1985 Dec;18(6):725-7.
  68. Machlin LJ. Clinical uses of vitamin E. Acta Vitaminol Enzymol 1985;7 Suppl:33-43.
  69. Elattar TM, et al. Biphasic action of vitamin E on the growth of human oral squamous carcinoma cells. Anticancer Res 1999 Jan-Feb;19(1A):365-8.
  70. Bairati I, et al. [Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers]. Bull Cancer Radiother 1996;83(1):12-6.